Pediatric rheumatology

Prognostic factors for disease progression and mortality of childhood-onset lupus nephritis in the Philippines: a retrospective cohort study in a tertiary hospital

Pediatr Rheumatol Online JPublished Retrospective cohort study

Authors' conclusion

Childhood-onset LN remains associated with high morbidity and mortality in the Philippines

Study context

Population
Patients under 19 years diagnosed with lupus nephritis (LN), January 2014 to December 2021, Philippine General Hospital (tertiary hospital)female-to-male ratio 13.2:1
Participants
128 participants
Outcome
Predictors of mortality and progression to CKD 5
Methodological detailssingle-centre, Kaplan-Meier survival, Cox proportional hazards regression, logistic regression
  • Single-centre
  • Kaplan-Meier survival
  • Cox proportional hazards regression
  • Logistic regression

Main finding

As reported in the abstract

Predictors of poor health outcomes:
  • Mortality
  • Progression to CKD 5

Nephrotic range proteinuria, HR

2.91

Hypertension at diagnosis, OR

5.57

Failure to achieve early partial response or complete remission, HR

3.69

Observational data: associations, not effects.

Further findings

Mortality during observation period · median follow-up 2.2 years (range, 0.0-8.8 years)

Patients who died
25 (19.5%)
Leading cause of mortality: infection

Kidney biopsy performed

Underwent kidney biopsy, mainly due to financial constraints
16%

Treatment delays and poor adherence

Treatment delays
60%
Poor adherence
38%
  • Largely due to financial hardship and limited healthcare access

Original publication

Prognostic factors for disease progression and mortality of childhood-onset lupus nephritis in the Philippines: a retrospective cohort study in a tertiary hospital. Pediatr Rheumatol Online J. Published 2 August 2025. doi:10.1186/s12969-025-01128-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.